Analyst Ratings For NASDAQ:KPTI – Karyopharm Therapeutics (NASDAQ:KPTI)
Today, NASDAQ:KPTI – Karyopharm Therapeutics (NASDAQ:KPTI) stock was downgraded by Wedbush from Outperform ➝ Neutral to with a price target of $20.00 ➝ $19.00.
Some recent analyst ratings include
- 5/24/2018-Wedbush was Downgraded by analysts at Wedbush from a “Outperform ➝ Neutral” rating to a “” rating. They now have a $20.00 ➝ $19.00 price target on the stock.
- 5/17/2018-HC Wainwright Reiterated Rating of Buy.
- 5/1/2018-Leerink Swann Reiterated Rating of Outperform.
- 4/25/2018-Jefferies Group Reiterated Rating of Buy.
- 4/10/2018-Canaccord Genuity Reiterated Rating of Buy.
Recent Insider Trading Activity For NASDAQ:KPTI – Karyopharm Therapeutics (NASDAQ:KPTI)
NASDAQ:KPTI – Karyopharm Therapeutics (NASDAQ:KPTI) has insider ownership of 13.26% and institutional ownership of 61.44%.
- On 5/18/2018 Michael Kauffman, CEO, sold 10,000 with an average share price of $19.39 per share and the total transaction amounting to $193,900.00.
- On 5/10/2018 Christopher Brett Primiano, EVP, sold 2,000 with an average share price of $18.01 per share and the total transaction amounting to $36,020.00.
- On 5/7/2018 Sharon Shacham, Insider, sold 10,000 with an average share price of $16.77 per share and the total transaction amounting to $167,700.00.
- On 4/18/2018 Michael Kauffman, CEO, sold 10,000 with an average share price of $14.79 per share and the total transaction amounting to $147,900.00.
- On 4/9/2018 Sharon Shacham, Insider, sold 10,000 with an average share price of $12.48 per share and the total transaction amounting to $124,800.00.
- On 3/19/2018 Michael Kauffman, CEO, sold 10,000 with an average share price of $15.29 per share and the total transaction amounting to $152,900.00.
- On 3/12/2018 Mansoor Raza Mirza, Director, sold 2,500 with an average share price of $17.01 per share and the total transaction amounting to $42,525.00.
Recent Trading Activity for NASDAQ:KPTI – Karyopharm Therapeutics (NASDAQ:KPTI)
Shares of NASDAQ:KPTI – Karyopharm Therapeutics closed the previous trading session at with 696483 shares trading hands.